{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:09:18Z","timestamp":1790464158226,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009938","name":"Knud H\u00f8jgaard&apos;s Fund","doi-asserted-by":"publisher","award":["23-01-2180"],"award-info":[{"award-number":["23-01-2180"]}],"id":[{"id":"10.13039\/501100009938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021851","name":"William Demant Foundation","doi-asserted-by":"publisher","award":["23\\u20132018"],"award-info":[{"award-number":["23\\u20132018"]}],"id":[{"id":"10.13039\/501100021851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006426","name":"Eva and Henry Fr\u00e6nkel Memorial Foundation","doi-asserted-by":"publisher","award":["10-09-2023"],"award-info":[{"award-number":["10-09-2023"]}],"id":[{"id":"10.13039\/501100006426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshall Fund","doi-asserted-by":"publisher","award":["07-05-2024"],"award-info":[{"award-number":["07-05-2024"]}],"id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127089","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:12:59Z","timestamp":1744348379000},"page":"127089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Human papillomavirus awareness, vaccination rate, and sociodemographic covariates of vaccination status in a low-income country: A cross-sectional study in the rural Busoga region of Uganda"],"prefix":"10.1016","volume":"53","author":[{"given":"Troels Alnor","family":"Einarson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Musana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Balonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katinka Bolette","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Kallestrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrethe","family":"Juncker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Okello","family":"Damoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Nakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Kallestrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127089_bb0005","unstructured":"WHO, Global strategy to accelerate the elimination of cervical cancer as a public health problem., Geneva: World Health Organization, Editor. 2020."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127089_bb0010","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical Cancer elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127089_bb0015","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127089_bb0020","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.biopha.2018.06.149","article-title":"The human papillomavirus (HPV)-related cancer biology: an overview","volume":"106","author":"Araldi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.vaccine.2025.127089_bb0025","author":"IARC"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2025.127089_bb0035","series-title":"Human papillomavirus vaccines: WHO position paper (2022 Update)","first-page":"645","author":"WHO","year":"2022"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127089_bb0040","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/ijc.26269","article-title":"Health and economic impact of HPV 16\/18 vaccination and cervical cancer screening in eastern Africa","volume":"130","author":"Campos","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2025.127089_bb0045","series-title":"Who cervical Cancer Elimination Initiative: From Call to action to global movement","author":"WHO","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127089_bb0050","series-title":"The World Bank, DataBank","year":"2024"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127089_bb0055","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"10224","key":"10.1016\/j.vaccine.2025.127089_bb0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127089_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/dc.21249","article-title":"Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based pap preparation","volume":"38","author":"Taube","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.vaccine.2025.127089_bb0070","series-title":"IARC, Cancer fact-sheet Uganda","first-page":"2","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127089_bb0075","series-title":"Gavi full country evaluations team, Gavi full country evaluations: 2016 dissemination report, Uganda","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127089_bb0080","series-title":"Cost and operational context of HPV vaccine delivery in Uganda","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127089_bb0085","series-title":"Parliament of Uganda, Immunisation Act, 2017","first-page":"11","year":"2017"},{"key":"10.1016\/j.vaccine.2025.127089_bb0090","series-title":"WHO, HPV immunization coverage estimates among primary target cohort (9\u201314 years old girls) (%)","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127089_bb0095","series-title":"Uganda National Expanded Programme on immunization (UNEPI), immunization performance report","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127089_bb0100","series-title":"Ministry of Health Uganda, THE NATIONAL CERVICAL CANCER PREVENTION AND CONTROL STRATEGIC PLAN 2021\u20132026","year":"2022"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0105","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s12879-023-08776-x","article-title":"Gaps in vaccine management practices during vaccination outreach sessions in rural settings in southwestern Uganda","volume":"23","author":"Flavia","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12889-020-8302-z","article-title":"Health system factors influencing uptake of human papilloma virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda","volume":"20","author":"Nabirye","year":"2020","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127089_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archpediatrics.2009.50","article-title":"Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings","volume":"163","author":"Bingham","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2025.127089_bb0125","series-title":"Mean international wealth index (IWI) score of region (Uganda)","author":"Global DataLab","year":"2016"},{"key":"10.1016\/j.vaccine.2025.127089_bb0130","series-title":"GDL Area Profile Report East Central (Busoga) (Uganda)","author":"Global DataLab","year":"2016"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12905-017-0365-3","article-title":"Women\u2019s knowledge and attitudes towards cervical cancer prevention: a cross sectional study in eastern Uganda","volume":"17","author":"Mukama","year":"2017","journal-title":"BMC Womens Health"},{"issue":"247","key":"10.1016\/j.vaccine.2025.127089_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/01621459.1949.10483314","article-title":"A procedure for objective respondent selection within the household","volume":"44","author":"Kish","year":"1949","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2025.127089_bb0150","series-title":"Uganda Bureau of Statistics, Projected population by district (2015\u20132030)","year":"2019"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12887-023-04174-z","article-title":"Knowledge, perceptions and uptake of human papilloma virus vaccine among adolescent girls in Kampala, Uganda; a mixed-methods school-based study","volume":"23","author":"Bitariho","year":"2023","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12889-017-4180-4","article-title":"Women's intention to screen and willingness to vaccinate their daughters against cervical cancer - a cross sectional study in eastern Uganda","volume":"17","author":"Ndejjo","year":"2017","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127089_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090912","article-title":"Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review","volume":"9","author":"Perlman","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127089_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003106","article-title":"Uptake of human papilloma virus vaccine among young women living in fishing communities in Wakiso and Mukono districts, Uganda","volume":"4","author":"Laban","year":"2024","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0175","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/s12889-024-18141-5","article-title":"Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis","volume":"24","author":"Agimas","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0180","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2326295","article-title":"Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: a systematic review and meta-analysis","volume":"20","author":"Asgedom","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127089_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.15171\/ijhpm.2017.37","article-title":"How are new vaccines prioritized in low-income countries? A case study of human papilloma virus vaccine and pneumococcal conjugate vaccine in Uganda","volume":"6","author":"Wallace","year":"2017","journal-title":"Int J Health Policy Manag"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0190","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1186\/s12889-022-13827-0","article-title":"Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies","volume":"22","author":"Asangbeh-Kerman","year":"2022","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127089_bb0195","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S1473-3099(20)30860-4","article-title":"Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis","volume":"21","author":"Drolet","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4314\/ahs.v15i1.5","article-title":"Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda","volume":"15","author":"Mugisha","year":"2015","journal-title":"Afr Health Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127089_bb0205","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100056","article-title":"Efficacy of single-dose HPV vaccination among young African women","volume":"1","author":"Barnabas","year":"2022","journal-title":"NEJM Evid"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127089_bb0210","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127089_bb0215","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127089_bb0220","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jnci\/djaa011","article-title":"Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial","volume":"112","author":"Kreimer","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0225","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0230","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2018.05.007","article-title":"Vaccination-induced herd immunity: successes and challenges","volume":"142","author":"Mallory","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127089_bb0235","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1080\/21645515.2018.1496878","article-title":"Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness","volume":"14","author":"Soe","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127089_bb0240","series-title":"Parliament of Uganda, The Anti-Homosexuality Act","volume":"2023","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127089_bb0245","first-page":"87","article-title":"Factors associated with the human papillomavirus vaccine coverage in Gulu District","volume":"14","author":"Odongo Ojok","year":"2023","journal-title":"Uganda Adolesc Health Med Ther"},{"key":"10.1016\/j.vaccine.2025.127089_bb0250","first-page":"77","article-title":"Human papillomavirus vaccination uptake and its predictors among female adolescents in Gulu municipality","volume":"13","author":"Aruho","year":"2022","journal-title":"Northern Uganda Adolesc Health Med Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12905-020-01014-5","article-title":"Factors associated with HPV vaccination uptake in Uganda: a multi-level analysis","volume":"20","author":"Isabirye","year":"2020","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127089_bb0260","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12905-023-02511-z","article-title":"Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study","volume":"23","author":"Nakayita","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.vaccine.2025.127089_bb0265","first-page":"184","article-title":"Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District","volume":"31","author":"Kisaakye","year":"2018","journal-title":"Uganda Pan Afr Med J"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2025.127204","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:42:51Z","timestamp":1762278171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":51,"alternative-id":["S0264410X2500386X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus awareness, vaccination rate, and sociodemographic covariates of vaccination status in a low-income country: A cross-sectional study in the rural Busoga region of Uganda","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127089"}}